Mostrar registro simples

dc.contributor.authorKlumb, Evandro Mendespt_BR
dc.contributor.authorScheinberg, Mortonpt_BR
dc.contributor.authorSouza, Viviane Angelina dept_BR
dc.contributor.authorXavier, Ricardo Machadopt_BR
dc.contributor.authorAzevedo, Valderílio Feijópt_BR
dc.contributor.authorMcElwee, Elizabethpt_BR
dc.contributor.authorRestrepo, Mariana Ricopt_BR
dc.contributor.authorMonticielo, Odirlei Andrépt_BR
dc.date.accessioned2022-07-28T04:45:32Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn0961-2033pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/245611pt_BR
dc.description.abstractPurpose: The objective of this review is to address the barriers limiting access to diagnosis and treatment of systemic lupus erythematosus (SLE) and lupus nephritis (LN) in Brazil, specifically for patients in the public healthcare system, arguably those with the least access to innovation. Design: A selected panel of Brazilian experts in SLE/LN were provided with a series of relevant questions to address in a multi-day conference. During the conference, responses were discussed and edited by the entire group through numerous drafts and rounds of discussion until a consensus was achieved. Results: The authors propose specific and realistic recommendations for implementing access to innovative diagnostic tools and treatment alternatives for SLE/LN in Brazil. Moreover, in creating these recommendations, the authors strived to address barriers and impediments for technology adoption. The multidisciplinary care required for SLE/LN necessitates the collective participation of all involved stakeholders. Conclusion: A great need exists to expand the adoption of innovative diagnostic tools and treatments for SLE/LN not only in Brazil but also in most countries, as access issues remain an urgent demand. The recommendations presented in this article can serve as a strategy for new technology adoption in other countries in a similar situation.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofLupus. London. Vol. 29, no. 9 (2021), p. 1140-1145pt_BR
dc.rightsOpen Accessen
dc.subjectLupus eritematoso sistêmicopt_BR
dc.subjectSystemic lupus erythematosusen
dc.subjectNefrite lúpicapt_BR
dc.subjectBrazilen
dc.subjectSLEen
dc.subjectTerapêuticapt_BR
dc.subjectLupus nephritisen
dc.subjectDiagnósticopt_BR
dc.subjectLNen
dc.subjectBrasilpt_BR
dc.subjectInnovative treatmentsen
dc.titleThe landscape of systemic lupus erythematosus in Brazil : an expert panel review and recommendationspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001146401pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples